The role of titin and extracellular matrix remodelling in heart failure with preserved ejection fraction
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1876-6250
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The role of titin and extracellular matrix remodelling in heart failure with preserved ejection fraction ; day:17 ; month:2 ; year:2016 ; pages:1-9
Netherlands heart journal ; (17.2.2016), 1-9
- Creator
-
Franssen, C.
- Contributor
-
González Miqueo, A.
SpringerLink (Online service)
- DOI
-
10.1007/s12471-016-0812-z
- URN
-
urn:nbn:de:1111-20160219202
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Franssen, C.
- González Miqueo, A.
- SpringerLink (Online service)
Other Objects (12)
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Biomarkers in heart failure with preserved ejection fraction
Comorbidities in heart failure with preserved ejection fraction
Animal models of heart failure with preserved ejection fraction
Heart Failure with Preserved Ejection Fraction—a Concise Review
133 Obesity is associated with decreased myocardial contraction fraction despite preserved ejection fraction
Gender-related differences in heart failure with preserved ejection fraction
Epicardial Adipose Tissue Thickness and Preserved Ejection Fraction Heart Failure
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Evaluation of mouse models of heart failure with preserved ejection fraction
Genetic architecture of heart failure with preserved versus reduced ejection fraction
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Biomarkers in heart failure with preserved ejection fraction
Comorbidities in heart failure with preserved ejection fraction
Animal models of heart failure with preserved ejection fraction
Heart Failure with Preserved Ejection Fraction—a Concise Review
133 Obesity is associated with decreased myocardial contraction fraction despite preserved ejection fraction
Gender-related differences in heart failure with preserved ejection fraction
Epicardial Adipose Tissue Thickness and Preserved Ejection Fraction Heart Failure
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Evaluation of mouse models of heart failure with preserved ejection fraction
Genetic architecture of heart failure with preserved versus reduced ejection fraction
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Biomarkers in heart failure with preserved ejection fraction
Comorbidities in heart failure with preserved ejection fraction
Animal models of heart failure with preserved ejection fraction
Heart Failure with Preserved Ejection Fraction—a Concise Review
133 Obesity is associated with decreased myocardial contraction fraction despite preserved ejection fraction
Gender-related differences in heart failure with preserved ejection fraction
Epicardial Adipose Tissue Thickness and Preserved Ejection Fraction Heart Failure
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Evaluation of mouse models of heart failure with preserved ejection fraction